InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the detailed record of transactions filed by Rizvi Syed Ali-aamir, Directeur Médical. Director active across 1 company, notably Caribou Biosciences, Inc.. Aggregated, 2 reports have been logged. History available since 25 January 2022. The latest transaction was filed on 25 January 2022 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations2 total
60,000 shares0Common stockSEC:0001209191-22-004860:0
60,000 shares0Common stockSEC:0001209191-22-004860
2 of 2 declarations
About Rizvi Syed Ali-aamir
Syed Ali-aamir Rizvi is the Chief Medical Officer at Caribou Biosciences, Inc. He is responsible for leading the company's medical and scientific initiatives. With expertise in biotechnology, Syed plays a key role in developing new treatments and therapies. His commitment to medical innovation is essential in ensuring that Caribou remains at the forefront of research and development.
